Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Affinity Biosensors
AddedFeb 15, 2024
UpdatedJun 18, 2026
Affinity Biosensors

Affinity Biosensors

Series A

Affinity Biosensors: Pioneering unique electronic measuring tools for research and life sciences since 2006.

HQ
Santa Barbara, CA, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

Founded in 2006 and based in Santa Barbara, California, Affinity Biosensors is dedicated to developing and manufacturing advanced analytical instruments for research, manufacturing, and life sciences. The company's core mission is to provide rapid and accurate diagnostic tools to combat rising antimicrobial resistance. Their flagship product, the LifeScale system, leverages Resonant Mass Measurement technology to offer unique and swift techniques for measuring and observing microbe growth and response.

Notable figures affiliated with Affinity Biosensors include its founding team of scientists and engineers who have driven innovation in electronic measuring equipment. The company has achieved significant milestones, including FDA clearance for the LifeScale AST system, which enhances diagnostic speed and accuracy in clinical settings. Affinity Biosensors' impact is evident in its contribution to faster diagnostics, which is crucial in addressing global health challenges such as antimicrobial resistance.

Affinity Biosensors - Quick Facts

When was Affinity Biosensors founded?

Affinity Biosensors was founded in 2006.

Where is Affinity Biosensors' headquarters located?

Affinity Biosensors' headquarters is located in Santa Barbara, CA, US.

When was Affinity Biosensors' last funding round?

Affinity Biosensors' most recent funding round was for $5M (USD) in November 2021.

How much has Affinity Biosensors raised to-date?

As of Nov 17, 2021, Affinity Biosensors has raised a total of $27.9M (USD).

How many employees does Affinity Biosensors have?

Affinity Biosensors has 25 employees as of Feb 5, 2024.

Affinity Biosensors - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Analytical Instruments
Tags
  • Biotech
  • Healthtech
NAICS
  • 333500Metalworking Machinery Manufacturing
  • 333510Metalworking Machinery Manufacturing
  • 333517Machine Tool Manufacturing
  • 330000Manufacturing
  • 333000Machinery Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries